<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-title>BMC Genomics</journal-title><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2164-7-227</article-id><article-id pub-id-type="pmid">16953885</article-id><article-id pub-id-type="doi">10.1186/1471-2164-7-227</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Genomic organization and evolution of the <italic>ULBP </italic>genes in cattle</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Larson</surname><given-names>Joshua H</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jhlarson@uiuc.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Marron</surname><given-names>Brandy M</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>bhaton@uiuc.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Beever</surname><given-names>Jonathan E</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jbeever@uiuc.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Roe</surname><given-names>Bruce A</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>broe@ou.edu</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Lewin</surname><given-names>Harris A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>h-lewin@uiuc.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Laboratory of Immunogenetics, Department of Animal Sciences, University of Illinois at Urbana-Champaign, 210 Edward R. Madigan Laboratory, 1201 W. Gregory Dr., Urbana, IL 61801, USA</aff><aff id="I2"><label>2</label>Laboratory of Molecular Genetics, Department of Animal Sciences, University of Illinois at Urbana-Champaign, 220 Edward R. Madigan Laboratory, 1201 W. Gregory Dr., Urbana, IL 61801, USA</aff><aff id="I3"><label>3</label>Department of Chemistry and Biochemistry, Advanced Center for Genome Technology, University of Oklahoma, 2107 Stephenson Research and Technology Center, 101 David L. Boren Blvd, Norman, OK 73069, USA</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>5</day><month>9</month><year>2006</year></pub-date><volume>7</volume><fpage>227</fpage><lpage>227</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2164/7/227"/><history><date date-type="received"><day>30</day><month>6</month><year>2006</year></date><date date-type="accepted"><day>5</day><month>9</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Larson et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Larson et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Larson H Joshua jhlarson@uiuc.edu </dc:author><dc:title> Genomic organization and evolution of the ULBP genes in cattle </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Genomics 7(1): 227-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2164(2006)7:1&#x0003c;227&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2164</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The cattle <italic>UL16-binding protein 1 </italic>(<italic>ULBP1</italic>) and <italic>ULBP2 </italic>genes encode members of the MHC Class I superfamily that have homology to the human <italic>ULBP </italic>genes. Human ULBP1 and ULBP2 interact with the NKG2D receptor to activate effector cells in the immune system. The human cytomegalovirus UL16 protein is known to disrupt the ULBP-NKG2D interaction, thereby subverting natural killer cell-mediated responses. Previous Southern blotting experiments identified evidence of increased <italic>ULBP </italic>copy number within the genomes of ruminant artiodactyls. On the basis of these observations we hypothesized that the cattle <italic>ULBP</italic>s evolved by duplication and sequence divergence to produce a sufficient number and diversity of ULBP molecules to deliver an immune activation signal in the presence of immunogenic peptides. Given the importance of the ULBPs in antiviral immunity in other species, our goal was to determine the copy number and genomic organization of the <italic>ULBP </italic>genes in the cattle genome.</p></sec><sec><title>Results</title><p>Sequencing of cattle bacterial artificial chromosome genomic inserts resulted in the identification of 30 cattle <italic>ULBP </italic>loci existing in two gene clusters. Evidence of extensive segmental duplication and approximately 14 Kbp of novel repetitive sequences were identified within the major cluster. Ten ULBPs are predicted to be expressed at the cell surface. Substitution analysis revealed 11 outwardly directed residues in the predicted extracellular domains that show evidence of positive Darwinian selection. These positively selected residues have only one residue that overlaps with those proposed to interact with NKG2D, thus suggesting the interaction with molecules other than NKG2D.</p></sec><sec><title>Conclusion</title><p>The <italic>ULBP </italic>loci in the cattle genome apparently arose by gene duplication and subsequent sequence divergence. Substitution analysis of the ULBP proteins provided convincing evidence for positive selection on extracellular residues that may interact with peptide ligands. These results support our hypothesis that the cattle ULBPs evolved under adaptive diversifying selection to avoid interaction with a UL16-like molecule whilst preserving the NKG2D binding site. The large number of ULBPs in cattle, their extensive diversification, and the high prevalence of bovine herpesvirus infections make this gene family a compelling target for studies of antiviral immunity.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The cattle <italic>Major Histocompatibility Complex Class I-like Gene Family A </italic>(<italic>MHCLA</italic>) was initially discovered in a cattle spleen cDNA library during a search for highly divergent mammalian genes [<xref ref-type="bibr" rid="B1">1</xref>]. Two transcripts, <italic>MHCLA1 </italic>and <italic>MHCLA2</italic>, were found to be members of the MHC Class I superfamily, encoding cell-surface transmembrane proteins containing &#x003b1;1- and &#x003b1;2-like domains, but no &#x003b1;3-like domain. These molecules have peptide sequence similarity to their homologues in other mammalian species, including the ULBP and RAET1 molecules in humans [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>] and the H60, RAE1 and MULT1 molecules in mice [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. To establish consistency with the human nomenclature, the cattle <italic>MHCLA1 </italic>and <italic>MHCLA2 </italic>genes are renamed <italic>ULBP1 </italic>and <italic>ULBP2</italic>, respectively, in this study. The function of cattle ULBP molecules is not known, but the human and mouse homologues have been demonstrated to interact with the NKG2D receptor, leading to activation of natural killer (NK) cells and T cell subsets in anti-tumour and infectious disease immunity [<xref ref-type="bibr" rid="B8">8</xref>]. In vitro studies have demonstrated that the soluble human cytomegalovirus (hCMV) protein UL16 interferes with the ability of ULBP1 and ULBP2 to interact with NKG2D, and co-expression of UL16 with ULBP1 or ULBP2 results in cytoplasmic retention of the ULBP molecules [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>].</p><p>Southern blot analysis revealed the existence of a high copy number of <italic>ULBP </italic>genes in the cattle genome and seven other ruminant genomes. It was thus hypothesized that the cattle <italic>ULBP </italic>genes evolved rapidly by duplication and sequence divergence in response to selective pressure exerted by a viral pathogen(s). Extensive duplication of the cattle <italic>ULBP </italic>genes may serve to increase the repertoire of ULBP molecules able to bind NKG2D to initiate an immune response even in the presence of a UL16-like molecule [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>The purpose of the present study was to identify the number of <italic>ULBP </italic>genes in cattle and describe their genomic organization. Six cattle bacterial artificial chromosome (BAC) clones were sequenced, resulting in the identification of 30 <italic>ULBP </italic>loci organized in two gene clusters on BTA9. Sequence analysis of the paralogues revealed that extensive gene duplication led to the present organization of the <italic>ULBP </italic>gene clusters. Bioinformatics tools were employed to characterize domains and sequence motifs in ten <italic>ULBP </italic>genes predicted to encode cell surface molecules, the majority of which are predicted glycoproteins. Substitution analysis identified specific codons in these genes that appear to be under positive Darwinian selection, and these selected sites were interpreted in a structural context using homology modelling.</p></sec><sec><title>Results &#x00026; discussion</title><sec><title>Identification of the minor and major <italic>ULBP </italic>gene clusters</title><p>Four minimally overlapping <italic>ULBP</italic>-containing BACs were identified by hybridization-based screening with a full-length cattle <italic>ULBP1 </italic>clone and then sequenced: RP42-147E22 [GenBank: <ext-link ext-link-type="gen" xlink:href="AC092858">AC092858</ext-link>], RP42-152A4 [GenBank: <ext-link ext-link-type="gen" xlink:href="AC096629">AC096629</ext-link>], RP42-146C17 [GenBank: <ext-link ext-link-type="gen" xlink:href="AC098686">AC098686</ext-link>] and RP42-194O5 [GenBank: <ext-link ext-link-type="gen" xlink:href="AC098687">AC098687</ext-link>]. Sequence alignment revealed that the former three BACs were overlapping, and the latter BAC was a singleton. Using BAC-end sequence data, two additional minimally overlapping BAC clones were identified: RP42-522F4 [GenBank: <ext-link ext-link-type="gen" xlink:href="DQ405274">DQ405274</ext-link>] and CHORI240-21B24 [GenBank: <ext-link ext-link-type="gen" xlink:href="DQ405273">DQ405273</ext-link>]. The overlapping clones were used to reconstruct two gene clusters, termed the "minor" <italic>ULBP </italic>cluster [GenBank: <ext-link ext-link-type="gen" xlink:href="DP000082">DP000082</ext-link>], spanning 331,973 bp, and the "major" <italic>ULBP </italic>cluster [GenBank: <ext-link ext-link-type="gen" xlink:href="DP000081">DP000081</ext-link>], spanning 464,586 bp (Table <xref ref-type="table" rid="T1">1</xref>). The minor and major cluster sequences could not be further extended or joined by querying publicly available cattle genome sequence data [NCBI Build 2.0]. The <italic>ULBP1 </italic>locus [<xref ref-type="bibr" rid="B1">1</xref>] was not identified in this study, and therefore the major <italic>ULBP </italic>cluster sequence may be incomplete upstream of <italic>ULBP7</italic>.</p><p>Four <italic>ULBP </italic>loci were identified within the minor cluster, and 26 <italic>ULBP </italic>loci were identified in the major cluster. Nine loci represent coding sequences, and 21 loci are probable pseudogenes. Exons were identified by alignment and manual inspection (Table <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="table" rid="T3">3</xref>). Loci were designated as genes if they contained uninterrupted coding sequence in the signal peptide, &#x003b1;1 and &#x003b1;2 domains. Loci either lacking an exon corresponding to the signal peptide, &#x003b1;1 or &#x003b1;2 domains or containing a stop codon in the coding sequence of one of these three domains were designated as pseudogenes. Many of the pseudogenes contain exons with intact coding sequence (Table <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="table" rid="T3">3</xref>). It may be speculated that these pseudogenes serve as a repository for generating novel <italic>ULBP </italic>paralogues through gene conversion.</p><p>The nine <italic>ULBP </italic>genes identified in this study have a canonical five exon structure. An exception is <italic>ULBP21</italic>, which has six exons; the first two exons encode the signal peptide. All nine <italic>ULBP </italic>genes contain GU/AG exon splicing motifs. Because of the high degree of interlocus sequence identity among <italic>ULBP </italic>genes (e.g., <italic>ULBP9 </italic>and <italic>ULBP27 </italic>have 99.8% nucleotide identity over 1252 bp), the assignment of expressed sequence tags (ESTs) to any particular locus was problematic. Thus, EST data could not be used to definitively support <italic>ULBP </italic>gene annotation.</p></sec><sec><title>Comparative genome organization</title><p>Both the cattle minor and major <italic>ULBP </italic>clusters were localized to BTA9 using radiation hybrid mapping methods (data not shown). Comparative analysis showed that <italic>STXBP5 </italic>and <italic>SAMDC1 </italic>share a conserved orientation on HSA6q and BTA9 (Figure <xref ref-type="fig" rid="F1">1</xref>). The cattle <italic>ULBP3, ULBP4, ULBP5 </italic>and <italic>ULBP6 </italic>loci located between <italic>STXBP5 </italic>and <italic>SAMDC1 </italic>likely originated by duplication and insertion of genes from the major <italic>ULBP </italic>cluster (see below).</p><p>The cattle <italic>NFYB </italic>gene is orthologous to human <italic>NFYB </italic>on HSA12 (Figure <xref ref-type="fig" rid="F1">1</xref>). Comparison of nucleotide alignments in the cattle minor <italic>ULBP </italic>cluster and HSA12 genomic sequence demonstrates that sequence similarity is limited to the <italic>NFYB </italic>gene. The absence of genomic sequence similarity flanking this gene in humans and the lack of intronic sequence in cattle <italic>NFYB </italic>suggests that the cattle <italic>NFYB </italic>locus represents a retrotransposed gene. Although unlikely, a chimeric cattle BAC clone or sequence assembly error in the human genome cannot be ruled out as an explanation for these findings.</p><p>The discovery of at least 30 distinct cattle <italic>ULBP </italic>paralogues makes cattle the species with the largest number of <italic>ULBP-</italic>like genes identified to date (Figure <xref ref-type="fig" rid="F1">1</xref>). Our findings confirm and extend previous Southern blot analysis indicating a large number of <italic>ULBP </italic>paralogues in cattle and seven other ruminant artiodactyl genomes [<xref ref-type="bibr" rid="B1">1</xref>]. In contrast, the more distantly related artiodactyls, swine and alpaca, appear to have relatively few <italic>ULBP </italic>genes [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B11">11</xref>].</p></sec><sec><title>The cattle <italic>ULBP </italic>loci evolved through extensive gene duplication</title><p>The cattle minor and major <italic>ULBP </italic>clusters were analyzed for internal nucleotide sequence similarity (Figure <xref ref-type="fig" rid="F2">2</xref> and Figure <xref ref-type="fig" rid="F3">3</xref>, respectively) in order to identify duplicated segments. The largest was a duplication of <italic>ULBP28</italic>, <italic>ULBP2</italic>, <italic>ULBP29</italic>, <italic>ULBP30</italic>, and <italic>ULBP31 </italic>to form <italic>ULBP16</italic>, <italic>ULBP17</italic>, <italic>ULBP18</italic>, <italic>ULBP19</italic>, and <italic>ULBP20 </italic>(Figure <xref ref-type="fig" rid="F3">3</xref>). The directionality of this duplication event was determined from the expansion of a novel cattle-specific repeat (see below) in the first intron of cattle <italic>ULBP17 </italic>as compared to the smaller corresponding repeat region in the first intron of <italic>ULBP2</italic>. There appear to be four tandem duplications involving blocks containing <italic>ULBP9 </italic>and <italic>ULBP10</italic>, <italic>ULBP11 </italic>and <italic>ULBP12</italic>, <italic>ULBP13 </italic>and <italic>ULBP14</italic>, and <italic>ULBP15 </italic>(Figure <xref ref-type="fig" rid="F3">3</xref>). However, similarity to <italic>ULBP27 </italic>was observed for <italic>ULBP9</italic>, <italic>ULBP11</italic>, <italic>ULBP13</italic>, and <italic>ULBP15</italic>, thus providing evidence that <italic>ULBP27 </italic>was likely also part of the large duplication involving <italic>ULBP28 </italic>through <italic>ULBP31 </italic>described above. In addition to the duplication events described above, there are two other segments that contain duplicated genes: i) <italic>ULBP7</italic>, <italic>ULBP8</italic>, and <italic>ULBP9 </italic>are related to <italic>ULBP22</italic>, <italic>ULBP23</italic>, and <italic>ULBP24</italic>, and ii) <italic>ULBP21 </italic>and <italic>ULBP22 </italic>are related to <italic>ULBP25 </italic>and <italic>ULBP26 </italic>(Figure <xref ref-type="fig" rid="F3">3</xref>).</p><p>Known repetitive elements were identified in the minor and major <italic>ULBP </italic>clusters (Table <xref ref-type="table" rid="T4">4</xref>). An additional novel genomic repeat was identified within the first introns of <italic>ULBP17 </italic>and <italic>ULBP2</italic>. The novel repeat spans 11,938 bp in the first intron of <italic>ULBP17 </italic>and 2,100 bp in the first intron of <italic>ULBP2 </italic>(Figure <xref ref-type="fig" rid="F3">3</xref>) [GenBank: <ext-link ext-link-type="gen" xlink:href="DP000081">DP000081</ext-link>]. These repeats are specific to the cattle major <italic>ULBP </italic>cluster and are not found elsewhere in the cattle genome. The large size of the <italic>ULBP17 </italic>repeat region relative to the corresponding repeat region in <italic>ULBP2 </italic>suggests active repeat expansion. A full understanding of the means by which these repeats contributed to the evolution of the <italic>ULBP </italic>gene family awaits complete genomic sequencing of this region and sequencing of additional haplotypes.</p></sec><sec><title>Structure and evolution of ULBP proteins</title><p>Conceptual translations of the nine cattle <italic>ULBP </italic>genes identified in this study and the previously identified cattle <italic>ULBP1 </italic>[<xref ref-type="bibr" rid="B1">1</xref>] are shown in Figure <xref ref-type="fig" rid="F4">4</xref>. Each molecule contains a 24 to 42 amino acid (aa) signal peptide sequence, an 88 aa &#x003b1;1 domain, an 84 aa &#x003b1;2 domain and a 25 to 30 aa connecting peptide region followed by a hydrophobic segment. Peptide sequence identity was determined within the &#x003b1;1 and &#x003b1;2 domains for each cattle ULBP and the porcine ULBP (Figure <xref ref-type="fig" rid="F5">5</xref>) [<xref ref-type="bibr" rid="B11">11</xref>]. ULBP9, ULBP21, and ULBP27 have glycophosphatidylinositol (GPI) anchor sites (P &#x0003c; 0.01, P &#x0003c; 0.05, and P &#x0003c; 0.001, respectively). The other seven ULBPs have predicted transmembrane domains of 23 to 25 aa followed by cytoplasmic tails ranging from 27 to 73 aa in length. The signal sequences and transmembrane domain or GPI anchor motifs indicate that all 10 of the expressed ULBPs are localized extracellularly. Each protein has predicted N-glycosylation motifs, with the exceptions of ULBP2 and ULBP17, suggesting that at least eight cattle ULBPs are glycoproteins.</p><p>Pairwise substitution analyses of ten <italic>ULBP </italic>genes showed an average global nonsynonymous to synonymous substitution ratio (&#x003c9;<sub>t</sub>) of 0.934 (Figure <xref ref-type="fig" rid="F6">6</xref>). Values of &#x003c9; &#x0003e; 1.0 are regarded as indicating that positive selection has operated on the sequences analyzed [<xref ref-type="bibr" rid="B12">12</xref>]; however, global substitution analysis is stringent and may mask evidence of positive selection in molecular subregions [<xref ref-type="bibr" rid="B13">13</xref>]. Heterogeneity in selection intensity was investigated within the ULBP &#x003b1;1 and &#x003b1;2 domain regions (Table <xref ref-type="table" rid="T5">5</xref>). In model 2 (M2), a continuous positive selection model with an additional (third) ratio of nonsynonymous to synonymous substitutions (&#x003c9;<sub>2</sub>) estimated from the data, &#x003c9;<sub>2 </sub>is 3.17, but represented only a small proportion (p<sub>2 </sub>= 0.08 out of 1.0) of codon sites. The log likelihood test of M2 vs. M1, the continuous neutrality model, was not statistically significant. In M3, the unconstrained discrete positive selection model, &#x003c9;<sub>2 </sub>is 1.90 with p<sub>2 </sub>= 0.28. The log likelihood test of M3 vs M1 was significant, providing evidence of heterogeneity in &#x003c9; ratios among codon sites. Model 8, a beta distribution with an added &#x003c9; class estimated from the data, was compared to M7, a beta distribution that did not allow for positively selected sites. The log likelihood test of M8 vs M7 was significant, allowing the detection of positively selected codon sites (Table <xref ref-type="table" rid="T5">5</xref>). Thirteen codon sites were determined to be under a high degree of positive selection (&#x0003e; 90% probability, Figure <xref ref-type="fig" rid="F4">4</xref>, Table <xref ref-type="table" rid="T5">5</xref>).</p><p>Twelve of the positively selected sites in the cattle ULBPs were mapped onto the three dimensional structure of human ULBP3 [PDB: <ext-link ext-link-type="pdb" xlink:href="1KCG">1KCG</ext-link>, chain C] (Figure <xref ref-type="fig" rid="F7">7</xref>). Eleven of the twelve positively selected residues were located at outwardly directed positions, indicating that positive selection acted at the level of interaction between the ULBPs and another molecule. On the basis of the structural data, fourteen human ULBP3 sites interact with NKG2D [<xref ref-type="bibr" rid="B14">14</xref>], and only one of these binding residues was found to overlap with the cattle ULBP sites under positive selection (Figure <xref ref-type="fig" rid="F7">7</xref>). Therefore, the positively selected cattle ULBP sites, located outside of the predicted NKG2D-binding residues on the basis of the homology modelling data, appear to interact with molecules other than NKG2D.</p><p>Several members of the Herpesviridae, which is the taxonomic family to which hCMV belongs, infect cattle, including bovine herpesviruses-1 through -5 and bovine lymphotrophic herpesvirus. The sequenced genomes of bovine herpesvirus-1, -4, and -5 do not encode molecules with detectable sequence similarity to UL16 of hCMV (HHV5); however it is conceivable that peptides encoded by the bovine herpesviruses or other viral pathogens may disrupt ULBP cell surface expression or the molecular interactions mediated by ULBP molecules. Thus, the rapid expansion of the <italic>ULBP </italic>gene family and the maintenance of such a large gene cluster are likely adaptive, serving to provide cattle with at least ten ULBP molecules through which an immune activation signal can be transmitted, even in the presence of an inhibitory pathogen-derived peptide.</p></sec></sec><sec><title>Conclusion</title><p>This study provides insights into the genomic organization and evolution of the cattle <italic>ULBP </italic>genes, a recently expanded MHC class I-like gene family in cattle with a probable role in antiviral immunity. For the first time, evidence of positive Darwinian selection on non-NKGD2-binding residues was obtained, strongly implicating immunogenic peptides as the driving force of molecular evolution of the cattle ULBPs. The stage is now set for studying the role ULBPs play in cattle immunity during infection by viral pathogens, as well as their organization and evolution in other mammals.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>BAC selection, isolation and sequencing</title><p>To identify BAC clones containing <italic>ULBP </italic>genes, filter membranes containing the RPCI-42 male Holstein BAC library (12X genome coverage; Children's Hospital Oakland Research Institute) were screened by Southern blot hybridization using the full-length <italic>ULBP1 </italic>[GenBank: <ext-link ext-link-type="gen" xlink:href="AF317556">AF317556</ext-link>] cDNA clone as a probe. Probe amplification and labelling, membrane hybridization, washing conditions and autoradiography were performed as previously described [<xref ref-type="bibr" rid="B1">1</xref>]. <italic>ULBP</italic>-containing BACs were cultured in 3 ml 2x LB media with 20 &#x003bc;g/ml chloramphenicol (Sigma) overnight at 37&#x000b0;C with shaking. Cultures were centrifuged at 3000 &#x000d7; <italic>g </italic>for 3 min. The cell pellet was resuspended in 400 &#x003bc;l of a solution containing 0.05 M Tris, 0.01 M EDTA (pH 7.5) and 50 &#x003bc;g/ml RNase A (Sigma), lysed by addition of 400 &#x003bc;l of a solution containing 0.2 N NaOH and 1% SDS, neutralized by addition of 400 &#x003bc;l of a solution containing 4 M guanidine-HCl and 0.75 M KOAc (pH 4.6), and centrifuged at 10,000 &#x000d7; <italic>g </italic>for 10 min. An 860 &#x003bc;l aliquot of cleared lysate was combined with 600 &#x003bc;l isopropanol, placed on ice for 15 min, and centrifuged at 10,000 &#x000d7; <italic>g </italic>for 5 min. The supernatant was decanted, and the pellet was washed with 500 &#x003bc;l 70% ethanol before centrifugation at 10,000 &#x000d7; <italic>g </italic>for 5 min. The dried pellet was suspended in 40 &#x003bc;l of a solution containing 10 mM Tris and 1 mM EDTA.</p><p>The BAC DNA was digested using the <italic>Hin</italic>dIII restriction enzyme, separated by electrophoresis on 1X TAE agarose, stained using SYBR Green (Invitrogen), and visualized using image analysis (Typhoon Visual Imaging System, Molecular Dynamics) according to an established protocol [<xref ref-type="bibr" rid="B15">15</xref>]. Gel images showing restriction fragments were analyzed semiautomatically using IMAGE v3.10b [<xref ref-type="bibr" rid="B16">16</xref>], and band migration information was analyzed using FPC v6.0 [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>] to determine clone overlap for contig assembly as previously described [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>The first round of sequencing was performed for four minimally overlapping <italic>ULBP</italic>-containing BACs [GenBank: <ext-link ext-link-type="gen" xlink:href="AC098687">AC098687</ext-link>, <ext-link ext-link-type="gen" xlink:href="AC092858">AC092858</ext-link>, <ext-link ext-link-type="gen" xlink:href="AC096629">AC096629</ext-link> and <ext-link ext-link-type="gen" xlink:href="AC098686">AC098686</ext-link>]. BAC DNA isolation, shotgun cloning, sequencing, quality analysis and sequence assembly were performed using established protocols [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. The sequenced BACs were aligned using BLASTN v2.2.13 [<xref ref-type="bibr" rid="B21">21</xref>] to generate one contiguous genomic DNA sequence containing three BACs and one singleton. Repetitive elements in the contiguous sequences were masked using REPEATMASKER v3.1.3 [<xref ref-type="bibr" rid="B22">22</xref>] before the sequences were used to query publicly available cattle genome trace sequences [NCBI Build 2.0] to identify additional minimally overlapping cattle BACs. Two additional <italic>ULBP</italic>-containing BAC clones were identified [GenBank: <ext-link ext-link-type="gen" xlink:href="DQ405273">DQ405273</ext-link> and <ext-link ext-link-type="gen" xlink:href="DQ405274">DQ405274</ext-link>], and a second round of sequencing was performed. Shotgun cloning and sequencing was performed using the Topo Shotgun Subcloning Kit (Invitrogen) according to the manufacturer's instructions. PHRED [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>] was used to remove low quality sequence (PHRED score &#x0003c; 20). CROSSMATCH and PHRAP [<xref ref-type="bibr" rid="B25">25</xref>] were used to remove vector sequence and assemble BAC subclone sequences, respectively. For the two BACs sequenced in the second round, sequence gaps were closed by primer walking. Contiguous sequences [GenBank: <ext-link ext-link-type="gen" xlink:href="DP000081">DP000081</ext-link> and <ext-link ext-link-type="gen" xlink:href="DP000082">DP000082</ext-link>] were constructed from overlapping full-clone BAC sequences using BLASTN. REPEATFINDER [<xref ref-type="bibr" rid="B26">26</xref>] was used to identify genomic sequence repeats not identified by REPEATMASKER.</p></sec><sec><title>Gene annotation and bioinformatic analysis</title><p>Loci were identified in the repeat-masked contiguous genomic sequences by BLASTN alignment to the GenBank nonredundant [Release 151] and dbEST [Release 012006] databases and by BLASTX alignment to the GenBank nonredundant coding sequence database. The previously identified <italic>ULBP1 </italic>[GenBank: <ext-link ext-link-type="gen" xlink:href="AF317556">AF317556</ext-link>] and <italic>ULBP2 </italic>[GenBank: <ext-link ext-link-type="gen" xlink:href="AY160681">AY160681</ext-link>] sequences were aligned to the genomic sequences using BLASTN to assist in the annotation of the <italic>ULBP </italic>genes. Exon/intron boundaries were verified by manual inspection and editing. For each locus identified, all exons were joined and conceptually translated using SIXFRAME [<xref ref-type="bibr" rid="B27">27</xref>] to identify open reading frames. Homologous positions in the human genome [NCBI Build 35] were identified using the UCSC Genome Browser [<xref ref-type="bibr" rid="B28">28</xref>].</p><p>The ULBP multiple alignment was constructed using CLUSTALX [<xref ref-type="bibr" rid="B29">29</xref>]. Signal peptides and transmembrane domains were predicted using PSORTII [<xref ref-type="bibr" rid="B30">30</xref>], TMPred [<xref ref-type="bibr" rid="B31">31</xref>] and TMHMM v2.0 [<xref ref-type="bibr" rid="B32">32</xref>]. N-glycosylation and GPI-anchor predictions were carried out using NetNGlyc v1.0 [<xref ref-type="bibr" rid="B33">33</xref>] and big-PI predictor [<xref ref-type="bibr" rid="B34">34</xref>]. Homology modelling was performed using Swiss-Model and Swiss-PdbViewer [<xref ref-type="bibr" rid="B35">35</xref>]. Large-scale alignments were performed for the contiguous sequences using PIPMAKER [<xref ref-type="bibr" rid="B36">36</xref>].</p></sec><sec><title>Substitution analysis</title><p>Ratios of nonsynonymous to synonymous substitutions (d<sub>N</sub>/d<sub>S </sub>or &#x003c9;) were determined for the <italic>ULBP </italic>genes using the PAML software package [<xref ref-type="bibr" rid="B37">37</xref>] to identify evidence of positive Darwinian selection. Cattle sequences used for the substitution analyses included: <italic>ULBP1 </italic>[GenBank: <ext-link ext-link-type="gen" xlink:href="AF317556">AF317556</ext-link>], <italic>ULBP4 </italic>[annotated in GenBank: <ext-link ext-link-type="gen" xlink:href="DP000082">DP000082</ext-link>], <italic>ULBP9</italic>, <italic>ULBP11, ULBP13</italic>, <italic>ULBP15</italic>, <italic>ULBP17</italic>, <italic>ULBP21</italic>, <italic>ULBP27 </italic>and <italic>ULBP2 </italic>[annotated in GenBank: <ext-link ext-link-type="gen" xlink:href="DP000081">DP000081</ext-link>]. Only the extracellular &#x003b1;1 and &#x003b1;2 domain regions were analyzed. The YN00 program in PAML was used to estimate &#x003c9;<sub>t </sub>for each group of aligned sequences using the method of Yang and Nielsen [<xref ref-type="bibr" rid="B38">38</xref>]. The CODEML program in PAML was used to identify variation in selection intensity. The data were modelled using maximum likelihood methods [<xref ref-type="bibr" rid="B39">39</xref>], and the results were compared to obtain a test statistic. Three comparisons were performed. Model M1, a neutrality model that constrained &#x003c9; to be either 0 or 1, was compared to both M2, a selection model that added an additional &#x003c9; ratio class estimated from the data, and M3, a selection model that used an unconstrained discrete distribution to model classes of &#x003c9; ratios. This analysis used three discrete classes for M3. In addition, M7, a continuous distribution neutrality model that estimates &#x003c9; using a beta function limited to the interval from 0 to 1, was compared to M8, a continuous distribution selection model that adds an additional class of sites with &#x003c9; estimated from the data and not constrained to the interval between 0 and 1. A test statistic of twice the negative value of the difference between the log likelihood values generated under each model was compared to a &#x003c7;<sup>2 </sup>distribution with degrees of freedom calculated from the difference in the number of model parameters (M2 vs M1, df = 2; M3 vs M1, df = 4; M8 vs M7, df = 2). Posterior probabilities for <italic>ULBP </italic>sites under positive selection were generated under M8.</p></sec></sec><sec><title>Authors' contributions</title><p>JHL carried out sequence analysis and annotation, substitution analysis, homology modelling, interpretation of data, participated in the design of the study, and drafted the manuscript. BMM carried out BAC clone fingerprinting and selection of minimally overlapping clones. JEB performed sequence analysis and assembly and participated in the design of the study. BAR contributed BAC sequences. HAL supervised the research, participated in the design of the study, interpretation of data, and drafting of the manuscript. All authors have read the manuscript, provided critical reviews of content, and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors thank: Denis Larkin at the University of Illinois, Urbana-Champaign, Yongjou Yoon, Steve Shaull, and Ziyun Yao of the Advanced Center for Genome Technology at the University of Oklahoma, and Alvaro Hernandez of the W.M. Keck Center for Comparative and Functional Genomics at the University of Illinois at Urbana-Champaign for technical advice and assistance with BAC sequencing. This study and the authors' contributions to it were funded by a grant to HAL from the USDA National Research Initiative (AG2002-35205-11625) and a grant to BAR from NIH NHGRI (HG02152). These funding bodies played no role in the design, collection, analysis, interpretation, writing, or the decision to submit the manuscript for publication.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>JH</given-names></name><name><surname>Rebeiz</surname><given-names>MJ</given-names></name><name><surname>Stiening</surname><given-names>CM</given-names></name><name><surname>Windish</surname><given-names>RL</given-names></name><name><surname>Beever</surname><given-names>JE</given-names></name><name><surname>Lewin</surname><given-names>HA</given-names></name></person-group><article-title>MHC class I-like genes in cattle, <italic>MHCLA </italic>,with similarity to genes encoding NK cell stimulatory ligands</article-title><source>Immunogenetics</source><year>2003</year><volume>55</volume><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12679856</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>M&#x000fc;llberg</surname><given-names>J</given-names></name><name><surname>Sutherland</surname><given-names>CL</given-names></name><name><surname>Chin</surname><given-names>W</given-names></name><name><surname>Armitage</surname><given-names>R</given-names></name><name><surname>Fanslow</surname><given-names>W</given-names></name><name><surname>Kubin</surname><given-names>M</given-names></name><name><surname>Chalupny</surname><given-names>NJ</given-names></name></person-group><article-title>ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor</article-title><source>Immunity</source><year>2001</year><volume>14</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">11239445</pub-id><pub-id pub-id-type="doi">10.1016/S1074-7613(01)00095-4</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radosavljevic</surname><given-names>M</given-names></name><name><surname>Cuillerier</surname><given-names>B</given-names></name><name><surname>Wilson</surname><given-names>MJ</given-names></name><name><surname>Cl&#x000e9;ment</surname><given-names>O</given-names></name><name><surname>Wicker</surname><given-names>S</given-names></name><name><surname>Gilfillan</surname><given-names>S</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name><name><surname>Bahram</surname><given-names>S</given-names></name></person-group><article-title>A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3</article-title><source>Genomics</source><year>2002</year><volume>79</volume><fpage>114</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">11827464</pub-id><pub-id pub-id-type="doi">10.1006/geno.2001.6673</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Takihara</surname><given-names>Y</given-names></name><name><surname>Shimada</surname><given-names>K</given-names></name></person-group><article-title>Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a <italic>Drosophila </italic>polyhomeotic protein</article-title><source>Differentiation</source><year>1994</year><volume>57</volume><fpage>39</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">8070621</pub-id><pub-id pub-id-type="doi">10.1046/j.1432-0436.1994.5710039.x</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Takihara</surname><given-names>Y</given-names></name><name><surname>Yasunaga</surname><given-names>T</given-names></name><name><surname>Shimada</surname><given-names>K</given-names></name></person-group><article-title>Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules</article-title><source>J Biochem (Tokyo)</source><year>1996</year><volume>119</volume><fpage>319</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">8882725</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malarkannan</surname><given-names>S</given-names></name><name><surname>Shih</surname><given-names>PP</given-names></name><name><surname>Eden</surname><given-names>PA</given-names></name><name><surname>Horng</surname><given-names>T</given-names></name><name><surname>Zuberi</surname><given-names>AR</given-names></name><name><surname>Christianson</surname><given-names>G</given-names></name><name><surname>Roopenian</surname><given-names>D</given-names></name><name><surname>Shastri</surname><given-names>N</given-names></name></person-group><article-title>The molecular and functional characterization of a dominant minor H antigen, H60</article-title><source>J Immunol</source><year>1998</year><volume>161</volume><fpage>3501</fpage><lpage>3509</lpage><pub-id pub-id-type="pmid">9759870</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carayannopoulos</surname><given-names>LN</given-names></name><name><surname>Naidenko</surname><given-names>OV</given-names></name><name><surname>Fremont</surname><given-names>DH</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>2825</fpage><lpage>2833</lpage><pub-id pub-id-type="pmid">16116168</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bahram</surname><given-names>S</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Shiina</surname><given-names>T</given-names></name><name><surname>Radosavljevic</surname><given-names>M</given-names></name></person-group><article-title>MIC and other NKG2D ligands: from none to too many</article-title><source>Curr Opin Immunol</source><year>2005</year><volume>17</volume><fpage>505</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">16087327</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubin</surname><given-names>M</given-names></name><name><surname>Cassiano</surname><given-names>L</given-names></name><name><surname>Chalupny</surname><given-names>J</given-names></name><name><surname>Chin</surname><given-names>W</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Fanslow</surname><given-names>W</given-names></name><name><surname>M&#x000fc;llberg</surname><given-names>J</given-names></name><name><surname>Rousseau</surname><given-names>AM</given-names></name><name><surname>Ulrich</surname><given-names>D</given-names></name><name><surname>Armitage</surname><given-names>R</given-names></name></person-group><article-title>ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells</article-title><source>Eur J Immunol</source><year>2001</year><volume>31</volume><fpage>1428</fpage><lpage>1437</lpage><pub-id pub-id-type="pmid">11465099</pub-id><pub-id pub-id-type="doi">10.1002/1521-4141(200105)31:5&#x0003c;1428::AID-IMMU1428&#x0003e;3.0.CO;2-4</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>C</given-names></name><name><surname>Chalupny</surname><given-names>NJ</given-names></name><name><surname>Sutherland</surname><given-names>CL</given-names></name><name><surname>Dosch</surname><given-names>S</given-names></name><name><surname>Sivakumar</surname><given-names>PV</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name></person-group><article-title>Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity</article-title><source>J Exp Med</source><year>2003</year><volume>197</volume><fpage>1427</fpage><lpage>1439</lpage><pub-id pub-id-type="pmid">12782710</pub-id><pub-id pub-id-type="doi">10.1084/jem.20022059</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Borges</surname><given-names>CN</given-names></name><name><surname>Phanavanh</surname><given-names>B</given-names></name><name><surname>Saraswati</surname><given-names>S</given-names></name><name><surname>Dennis</surname><given-names>RA</given-names></name><name><surname>Crew</surname><given-names>MD</given-names></name></person-group><article-title>Molecular cloning and characterization of a porcine UL16 binding protein (ULBP)-like cDNA</article-title><source>Mol Immunol</source><year>2005</year><volume>42</volume><fpage>665</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">15781110</pub-id><pub-id pub-id-type="doi">10.1016/j.molimm.2004.09.020</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nei</surname><given-names>M</given-names></name><name><surname>Gojobori</surname><given-names>T</given-names></name></person-group><article-title>Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions</article-title><source>Mol Biol Evol</source><year>1986</year><volume>3</volume><fpage>418</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">3444411</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>T</given-names></name><name><surname>Ikeo</surname><given-names>K</given-names></name><name><surname>Gojobori</surname><given-names>T</given-names></name></person-group><article-title>Large-scale search for genes on which positive selection may operate</article-title><source>Mol Biol Evol</source><year>1996</year><volume>13</volume><fpage>685</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">8676743</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radaev</surname><given-names>S</given-names></name><name><surname>Rostro</surname><given-names>B</given-names></name><name><surname>Brooks</surname><given-names>AG</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>PD</given-names></name></person-group><article-title>Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3</article-title><source>Immunity</source><year>2001</year><volume>15</volume><fpage>1039</fpage><lpage>1049</lpage><pub-id pub-id-type="pmid">11754823</pub-id><pub-id pub-id-type="doi">10.1016/S1074-7613(01)00241-2</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>Kucaba</surname><given-names>TA</given-names></name><name><surname>Dietrich</surname><given-names>NL</given-names></name><name><surname>Green</surname><given-names>ED</given-names></name><name><surname>Brownstein</surname><given-names>B</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>McDonald</surname><given-names>KM</given-names></name><name><surname>Hillier</surname><given-names>LW</given-names></name><name><surname>McPherson</surname><given-names>JD</given-names></name><name><surname>Waterston</surname><given-names>RH</given-names></name></person-group><article-title>High throughput fingerprint analysis of large-insert clones</article-title><source>Genome Res</source><year>1997</year><volume>7</volume><fpage>1072</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">9371743</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sulston</surname><given-names>J</given-names></name><name><surname>Mallett</surname><given-names>F</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><name><surname>Horsnell</surname><given-names>T</given-names></name></person-group><article-title>Image analysis of restriction enzyme fingerprint autoradiograms</article-title><source>Bioinformatics</source><year>1989</year><volume>5</volume><fpage>101</fpage><lpage>106</lpage></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soderlund</surname><given-names>C</given-names></name><name><surname>Longden</surname><given-names>I</given-names></name><name><surname>Mott</surname><given-names>R</given-names></name></person-group><article-title>FPC: A system for building contigs from restriction fingerprinted clones</article-title><source>CABIOS</source><year>1997</year><volume>13</volume><fpage>523</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">9367125</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soderlund</surname><given-names>C</given-names></name><name><surname>Humphray</surname><given-names>S</given-names></name><name><surname>Dunham</surname><given-names>A</given-names></name><name><surname>French</surname><given-names>L</given-names></name></person-group><article-title>Contigs built with fingerprints, markers, and FPC V4.7</article-title><source>Genome Res</source><year>2000</year><volume>10</volume><fpage>1772</fpage><lpage>1787</lpage><pub-id pub-id-type="pmid">11076862</pub-id><pub-id pub-id-type="doi">10.1101/gr.GR-1375R</pub-id></citation></ref><ref id="B19"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Roe</surname><given-names>BA</given-names></name><name><surname>Crabtree</surname><given-names>JS</given-names></name><name><surname>Khan</surname><given-names>AS</given-names></name></person-group><source>DNA Isolation and Sequencing</source><year>1996</year><publisher-name>Hoboken: John Wiley and Sons</publisher-name></citation></ref><ref id="B20"><citation citation-type="other"><article-title>Protocols used in the Roe Laboratory</article-title><ext-link ext-link-type="uri" xlink:href="http://www.genome.ou.edu/proto.html"/></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Madden</surname><given-names>TL</given-names></name><name><surname>Schaffer</surname><given-names>AA</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><fpage>3389</fpage><lpage>3402</lpage><pub-id pub-id-type="pmid">9254694</pub-id><pub-id pub-id-type="doi">10.1093/nar/25.17.3389</pub-id></citation></ref><ref id="B22"><citation citation-type="other"><article-title>Repeatmasker</article-title><ext-link ext-link-type="uri" xlink:href="http://www.repeatmasker.org"/></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewing</surname><given-names>B</given-names></name><name><surname>Hillier</surname><given-names>L</given-names></name><name><surname>Wendl</surname><given-names>MC</given-names></name><name><surname>Green</surname><given-names>P</given-names></name></person-group><article-title>Base-calling of automated sequencer traces using phred. I. Accuracy assessment</article-title><source>Genome Res</source><year>1998</year><volume>8</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">9521921</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewing</surname><given-names>B</given-names></name><name><surname>Green</surname><given-names>P</given-names></name></person-group><article-title>Base-calling of automated sequencer traces using phred. II. Error probabilities</article-title><source>Genome Res</source><year>1998</year><volume>8</volume><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">9521922</pub-id></citation></ref><ref id="B25"><citation citation-type="other"><article-title>PHRED, PHRAP, CONSED</article-title><ext-link ext-link-type="uri" xlink:href="http://www.phrap.org/phredphrapconsed.html"/></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Volfovsky</surname><given-names>N</given-names></name><name><surname>Haas</surname><given-names>BJ</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>A clustering method for repeat analysis in DNA sequences</article-title><source>Genome Biol</source><year>2001</year><volume>2</volume><fpage>RESEARCH0027.1</fpage><lpage>0027.11</lpage><pub-id pub-id-type="pmid">11532211</pub-id><pub-id pub-id-type="doi">10.1186/gb-2001-2-8-research0027</pub-id></citation></ref><ref id="B27"><citation citation-type="other"><article-title>Biology Workbench</article-title><ext-link ext-link-type="uri" xlink:href="http://workbench.sdsc.edu/"/></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Sugnet</surname><given-names>CW</given-names></name><name><surname>Furey</surname><given-names>TS</given-names></name><name><surname>Roskin</surname><given-names>KM</given-names></name><name><surname>Pringle</surname><given-names>TH</given-names></name><name><surname>Zahler</surname><given-names>AM</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name></person-group><article-title>The human genome browser at UCSC</article-title><source>Genome Res</source><year>2002</year><volume>12</volume><fpage>996</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">12045153</pub-id><comment>10.1101/gr.229102. Article published online before print in May 2002</comment></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeanmougin</surname><given-names>F</given-names></name><name><surname>Thompson</surname><given-names>JD</given-names></name><name><surname>Gouy</surname><given-names>M</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name><name><surname>Gibson</surname><given-names>TJ</given-names></name></person-group><article-title>Multiple sequence alignment with Clustal X</article-title><source>Trends Biochem Sci</source><year>1998</year><volume>23</volume><fpage>403</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">9810230</pub-id><pub-id pub-id-type="doi">10.1016/S0968-0004(98)01285-7</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakai</surname><given-names>K</given-names></name><name><surname>Kanehisa</surname><given-names>M</given-names></name></person-group><article-title>A knowledge base for predicting protein localization sites in eukaryotic cells</article-title><source>Genomics</source><year>1992</year><volume>14</volume><fpage>897</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">1478671</pub-id><pub-id pub-id-type="doi">10.1016/S0888-7543(05)80111-9</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>K</given-names></name><name><surname>Stoffel</surname><given-names>W</given-names></name></person-group><article-title>Tmbase &#x02013; a database of membrane spanning protein segments</article-title><source>Biol Chem Hoppe-Seyler</source><year>1993</year><volume>374</volume><fpage>166</fpage></citation></ref><ref id="B32"><citation citation-type="other"><article-title>TMHMM Server v. 2.0</article-title><ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/TMHMM-2.0/"/></citation></ref><ref id="B33"><citation citation-type="other"><article-title>NetNGlyc 1.0 Server</article-title><ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/NetNGlyc/"/></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eisenhaber</surname><given-names>B</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Eisenhaber</surname><given-names>F</given-names></name></person-group><article-title>Prediction of potential GPI-modification sites in proprotein sequences</article-title><source>J Mol Biol</source><year>1999</year><volume>292</volume><fpage>741</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">10497036</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.1999.3069</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>MC</given-names></name></person-group><article-title>SWISS-MODEL and the Swiss-PdbViewer an environment for comparative protein modeling</article-title><source>Electrophoresis</source><year>1997</year><volume>18</volume><fpage>2714</fpage><lpage>2723</lpage><pub-id pub-id-type="pmid">9504803</pub-id><pub-id pub-id-type="doi">10.1002/elps.1150181505</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Frazer</surname><given-names>KA</given-names></name><name><surname>Smit</surname><given-names>A</given-names></name><name><surname>Riemer</surname><given-names>C</given-names></name><name><surname>Bouck</surname><given-names>J</given-names></name><name><surname>Gibbs</surname><given-names>R</given-names></name><name><surname>Hardison</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name></person-group><article-title>PipMaker-A Web Server for Aligning Two Genomic DNA Sequences</article-title><source>Genome Res</source><year>2000</year><volume>10</volume><fpage>577</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">10779500</pub-id><pub-id pub-id-type="doi">10.1101/gr.10.4.577</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>PAML: a program package for phylogenetic analysis by maximum likelihood</article-title><source>Comput Appl Biosci</source><year>1997</year><volume>13</volume><fpage>555</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">9367129</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name></person-group><article-title>Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models</article-title><source>Mol Biol Evol</source><year>2000</year><volume>17</volume><fpage>32</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">10666704</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name><name><surname>Goldman</surname><given-names>N</given-names></name><name><surname>Pedersen</surname><given-names>AM</given-names></name></person-group><article-title>Codon-substitution models for heterogeneous selection pressure at amino acid sites</article-title><source>Genetics</source><year>2000</year><volume>155</volume><fpage>431</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">10790415</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Scaled comparative map showing homologous <italic>ULBP</italic>-containing chromosome regions in cattle and human. </bold>Arrows indicate gene orientation. The BTA9 upper and lower seqments represent the major and minor <italic>ULBP </italic>clusters, respectively. Cattle BAC contig sizes and gene positions are found in Tables 1-3. The upper and lower chromosomal segments from HSA6q depict sequence positions 147,566&#x02013;148,013 Kbp and 150,302&#x02013;150,482 Kbp [NCBI Build 35], respectively. The HSA12 chromosomal segment represents positions 103,013&#x02013;103,034 Kbp [NCBI Build 35].</p></caption><graphic xlink:href="1471-2164-7-227-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Internal sequence identity plot of the minor <italic>ULBP </italic>cluster. </bold>Sequence numbers displayed on the X- and Y-axes indicate alignment orientation, originating in the lower left corner. The central diagonal line represents identity; other lines indicate regions of internal sequence identity. Genes are annotated above the figure with arrows indicating orientation. Nucleotide sequences used to construct the minor <italic>ULBP </italic>cluster are listed in Table 1.</p></caption><graphic xlink:href="1471-2164-7-227-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Internal sequence identity plot of the major <italic>ULBP </italic>cluster. </bold>Sequence numbers displayed on the X- and Y-axes indicate alignment orientation, originating in the lower left corner. The center line represents identity; other lines indicate regions of internal sequence identity. Genes are annotated above the figure with arrows indicating orientation. Nucleotide sequences used to construct the major <italic>ULBP </italic>cluster are listed in Table 1. The duplication of <italic>ULBP28</italic>-<italic>ULBP31 </italic>to form <italic>ULBP16</italic>-<italic>ULBP20 </italic>is within the red shaded area. The cattle specific repeat regions within <italic>ULBP17 </italic>and <italic>ULBP2 </italic>are indicated by red asterisks. The duplication of <italic>ULBP7</italic>-<italic>ULBP9 </italic>corresponding to <italic>ULBP22</italic>-<italic>ULBP24 </italic>is within the blue shaded area. The duplication of <italic>ULBP21</italic>-<italic>ULBP22 </italic>corresponding to <italic>ULBP25</italic>-<italic>ULBP26 </italic>is within the green shaded area. The tandem duplications of <italic>ULBP9 </italic>and <italic>ULBP10</italic>, <italic>ULBP11 </italic>and <italic>ULBP12</italic>, <italic>ULBP13 </italic>and <italic>ULBP14</italic>, and <italic>ULBP15 </italic>are within the yellow shaded area, and lines showing their similarity to the <italic>ULBP27 </italic>region are within the violet shaded area.</p></caption><graphic xlink:href="1471-2164-7-227-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Protein alignment of the cattle ULBP family. </bold>Alignment gaps are represented by periods, and aligned ULBP sites sharing identity with cattle ULBP1 are represented by dashes. The signal peptide region (sp) is represented by dashes within brackets above the alignment. The &#x003b1;1 and &#x003b1;2 domains are designated by an underscore above the alignment. Universally conserved cysteine, proline, and tryptophan residues are annotated with Cs, Ps and Ws, respectively, beneath the alignment. Predicted N-glycosylation motifs are represented by underlined text in the alignment. Transmembrane domains are represented by black shaded background. Predicted GPI anchor motifs are represented by gray shaded background, and the associated downstream hydrophobic regions are indicated by italicized text with gray shaded background. Positively selected sites are indicated by asterisks above the alignment, and posterior probabilities associated with each positively selected site (see Table 2.5) are represented within the alignment by normal text (probability &#x0003e; 0.90), bold text (probability &#x0003e; 0.95), and italicized bold text (probability &#x0003e; 0.99).</p></caption><graphic xlink:href="1471-2164-7-227-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Sequence identity in the extracellular domains ofcattle and swine ULBPs. </bold>Percent pair-wise sequence identity between the &#x003b1;1 and &#x003b1;2 domains of ten cattle ULBP proteins and porcine ULBP [GenBank: <ext-link ext-link-type="gen" xlink:href="AAP81932">AAP81932</ext-link>]. Sequence alignments were made using BLASTP and edited manually.</p></caption><graphic xlink:href="1471-2164-7-227-5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Global substitution analysis of ten <italic>ULBP </italic>paralogues. </bold>The bold numerical values correspond to &#x003c9;<sub>t </sub>ratios; raw d<sub>N</sub>/d<sub>S </sub>values are listed in parentheses. Accession numbers associated with each sequence analyzed are listed in the Methods.</p></caption><graphic xlink:href="1471-2164-7-227-6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Positively selected ULBP sites mapped onto the crystal structure of human ULBP3. </bold>Positively selected cattle ULBP sites mapped onto the structure of human ULBP3. Tertiary structure of human ULBP3 [PDB: <ext-link ext-link-type="pdb" xlink:href="1KCG">1KCG</ext-link>, chain C] showing the spatial arrangement of homologous cattle ULBP residues under positive selection (&#x0003e;90% probability) as well as the human ULBP3 residues that interact with the NKG2D molecule. The human ULBP3 backbone appears in blue and green. Twelve of 13 cattle ULBP sites under positive selection are mapped onto the structure, and eleven appear as red space-filling residues. Thirteen of the fourteen human ULBP3 sites that interact with NKG2D appear as yellow space-filling residues. One site corresponding to both a selected cattle ULBP site and a human ULBP3 site that interacts with NKG2D appears in orange.</p></caption><graphic xlink:href="1471-2164-7-227-7"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>BAC clone composition of the assembled <italic>ULBP </italic>gene clusters</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Assembled <italic>ULBP </italic>cluster (bp)</td><td align="center">Component BAC clone (accession)</td><td align="center">Size (bp)</td><td align="center">Orient.</td><td align="center">Component BAC sequence regions used in assembly</td><td align="center">Corresponding <italic>ULBP </italic>cluster region</td></tr></thead><tbody><tr><td align="center">Minor <italic>ULBP </italic>cluster (331,973)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td align="center">RPCI42-194O5 (<ext-link ext-link-type="gen" xlink:href="AC098687">AC098687</ext-link>)</td><td align="center">156,543</td><td align="center">+</td><td align="center">5-156,543</td><td align="center">1-156,539</td></tr><tr><td></td><td align="center">RPCI42-522F4 (<ext-link ext-link-type="gen" xlink:href="DQ405274">DQ405274</ext-link>)</td><td align="center">202,200</td><td align="center">+</td><td align="center">26,767&#x02013;202,200</td><td align="center">156,540&#x02013;331,973</td></tr><tr><td align="center">Major <italic>ULBP </italic>cluster (464,586)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td align="center">CHORI240-21B24 (<ext-link ext-link-type="gen" xlink:href="DQ405273">DQ405273</ext-link>)</td><td align="center">116,254</td><td align="center">+</td><td align="center">1-98,955</td><td align="center">1-98,955</td></tr><tr><td></td><td align="center">RPCI42-147E22 (<ext-link ext-link-type="gen" xlink:href="AC092858">AC092858</ext-link>)</td><td align="center">165,590</td><td align="center">-</td><td align="center">165,584-28,446</td><td align="center">98,956-236,094</td></tr><tr><td></td><td align="center">RPCI42-152A4 (<ext-link ext-link-type="gen" xlink:href="AC096629">AC096629</ext-link>)</td><td align="center">191,732</td><td align="center">-</td><td align="center">185,338-121,525</td><td align="center">236,095&#x02013;299,908</td></tr><tr><td></td><td align="center">RPCI42-146C17 (<ext-link ext-link-type="gen" xlink:href="AC098686">AC098686</ext-link>)</td><td align="center">164,686</td><td align="center">+</td><td align="center">9-164,686</td><td align="center">299,909&#x02013;464,586</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Genomic annotation of the minor <italic>ULBP </italic>gene cluster</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Locus</td><td align="center">Status</td><td align="center">Orient.</td><td align="center">Exon</td><td align="right">Exon position (bp)</td><td align="center">Size (bp)</td><td align="center">Stop codon</td></tr></thead><tbody><tr><td align="center"><italic>STXBP5</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">11</td><td align="right">1,039&#x02013;1,186</td><td align="center">148</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">12</td><td align="right">1,390&#x02013;1,456</td><td align="center">67</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">13</td><td align="right">2,620&#x02013;2,840</td><td align="center">221</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">14</td><td align="right">3,330&#x02013;3,508</td><td align="center">179</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">15</td><td align="right">10,247&#x02013;10,372</td><td align="center">126</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">16</td><td align="right">12,700&#x02013;12,851</td><td align="center">152</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">17</td><td align="right">18,793&#x02013;18,858</td><td align="center">66</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">18</td><td align="right">43,553&#x02013;43,645</td><td align="center">93</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">19</td><td align="right">44,900&#x02013;45,269</td><td align="center">370</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">20</td><td align="right">45,574&#x02013;45,739</td><td align="center">166</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">21</td><td align="right">53,349&#x02013;53,460</td><td align="center">112</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">22</td><td align="right">57,390&#x02013;57,614</td><td align="center">225</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">23</td><td align="right">59,839&#x02013;60,297</td><td align="center">459</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP3</italic></td><td align="center">pseudogene</td><td align="center">+</td><td align="center">3</td><td align="right">101,446&#x02013;101,579</td><td align="center">134</td><td align="center">No</td></tr><tr><td align="center"><italic>ULBP4</italic></td><td align="center">gene</td><td align="center">-</td><td align="center">1</td><td align="right">132,643-132,512</td><td align="center">132</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">124,691-124,428</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">124,189-123,914</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">123,310-123,175</td><td align="center">136</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">121,996-121,521</td><td align="center">476</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP5</italic></td><td align="center">pseudogene</td><td align="center">+</td><td align="center">2</td><td align="right">137,458&#x02013;137,605</td><td align="center">148</td><td align="center">No</td></tr><tr><td align="center"><italic>ULBP6</italic></td><td></td><td align="center">+</td><td align="center">2</td><td align="right">154,996-155,258</td><td align="center">263</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">155,474&#x02013;155,749</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">156,396&#x02013;156,527</td><td align="center">132</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">157,711&#x02013;157,835</td><td align="center">125</td><td align="center">Yes</td></tr><tr><td align="center"><italic>NFYB</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">184,327&#x02013;185,342</td><td align="center">1,016</td><td align="center">Yes</td></tr><tr><td align="center"><italic>SAMDC1</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">230,021&#x02013;230,485</td><td align="center">465</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">290,210&#x02013;290,272</td><td align="center">63</td><td align="center">Yes</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Genomic annotation of the major <italic>ULBP </italic>gene cluster</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Locus</td><td align="center">Status</td><td align="center">Orient.</td><td align="center">Exon</td><td align="right">Exon position (bp)</td><td align="center">Size (bp)</td><td align="center">Stop codon</td></tr></thead><tbody><tr><td align="center"><italic>ULBP7</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">8,262-8,018</td><td align="center">245</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">7,790-7,515</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">6,890-6,759</td><td align="center">132</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">5,578-5,454</td><td align="center">125</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP8</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">24,180-23,979</td><td align="center">202</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP9</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">28,719&#x02013;28,813</td><td align="center">95</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">37,552&#x02013;37,815</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">38,054&#x02013;38,329</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">38,934&#x02013;39,066</td><td align="center">133</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">39,881&#x02013;40,391</td><td align="center">511</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP10</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">51,618-51,357</td><td align="center">262</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">51,115-50,835</td><td align="center">281</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP11</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">55,298-55,409</td><td align="center">112</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">64,155-64,418</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">64,656-64,931</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">65,535-65,667</td><td align="center">133</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">66,814-67,324</td><td align="center">511</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP12</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">78,583-78,389</td><td align="center">195</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">78,079-77,816</td><td align="center">264</td><td align="center">No</td></tr><tr><td align="center"><italic>ULBP13</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">82,210&#x02013;82,345</td><td align="center">136</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">91,064&#x02013;91,327</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">91,564&#x02013;91,839</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">92,443&#x02013;92,578</td><td align="center">136</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">93,722&#x02013;94,227</td><td align="center">506</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP14</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">105,503&#x02013;105,240</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">105,005-104,733</td><td align="center">273</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP15</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">109,168&#x02013;109,278</td><td align="center">111</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">117,844&#x02013;118,107</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">118,345&#x02013;118,620</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">119,224&#x02013;119,356</td><td align="center">133</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">120,500&#x02013;121,003</td><td align="center">504</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP16</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">141,435-141,160</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">140,931-140,666</td><td align="center">266</td><td align="center">No</td></tr><tr><td align="center"><italic>ULBP17</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">160,588&#x02013;160,721</td><td align="center">134</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">178,284&#x02013;178,547</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">178,782&#x02013;179,057</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">179,685&#x02013;179,817</td><td align="center">133</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">181,195&#x02013;181,591</td><td align="center">397</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP18</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">194,201-194,003</td><td align="center">199</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">192,969-192,694</td><td align="center">276</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP19</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">205,757-205,495</td><td align="center">263</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">205,259&#x02013;204,985</td><td align="center">275</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">204,053-203,923</td><td align="center">131</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP20</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">3</td><td align="right">215,364-215,116</td><td align="center">249</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP21</italic></td><td align="center">gene</td><td align="center">-</td><td align="center">1</td><td align="right">230,458-230,371</td><td align="center">88</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">227,628-227,590</td><td align="center">39</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">226,923-226,660</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">226,284-226,009</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">224,903-224,771</td><td align="center">133</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">6</td><td align="right">223,621-223,508</td><td align="center">114</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP22</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">247,327-247,005</td><td align="center">263</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">246,855-246,580</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">245,961-245,830</td><td align="center">132</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">244,644-244,532</td><td align="center">113</td><td align="center">No</td></tr><tr><td align="center"><italic>ULBP23</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">264,695-264,431</td><td align="center">264</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP24</italic></td><td align="center">pseudogene</td><td align="center">+</td><td align="center">1</td><td align="right">270,030&#x02013;270,163</td><td align="center">134</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">277,941&#x02013;278,215</td><td align="center">275</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">278,442&#x02013;278,717</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">279,606&#x02013;279,738</td><td align="center">133</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">280,568&#x02013;281,054</td><td align="center">487</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP25</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">1</td><td align="right">300,310-300,223</td><td align="center">88</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">296,899-296,861</td><td align="center">39</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">296,194-295,931</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">295,553-295,279</td><td align="center">275</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">294,125-294,015</td><td align="center">111</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">6</td><td align="right">292,846-292,384</td><td align="center">463</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP26</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">1</td><td align="right">322,695-322,562</td><td align="center">134</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">316,336-316,098</td><td align="center">239</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">315,865-315,589</td><td align="center">277</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">314,950-314,815</td><td align="center">136</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">314,113-313,670</td><td align="center">444</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP27</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">336,705&#x02013;336,840</td><td align="center">134</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">345,589&#x02013;345,852</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">346,091&#x02013;346,366</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">346,971&#x02013;347,103</td><td align="center">133</td><td align="center">Yes</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">347,918&#x02013;348,404</td><td align="center">487</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP28</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">359,653-359,390</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">359,148-358,883</td><td align="center">266</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">358,026-357,887</td><td align="center">140</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP2</italic></td><td align="center">gene</td><td align="center">+</td><td align="center">1</td><td align="right">378,496&#x02013;378,629</td><td align="center">134</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">2</td><td align="right">386,342&#x02013;386,605</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">386,840&#x02013;387,115</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">387,763&#x02013;387,895</td><td align="center">133</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">5</td><td align="right">389,276&#x02013;389,762</td><td align="center">487</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP29</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">402,249-402,066</td><td align="center">184</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">401,018-400,743</td><td align="center">276</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP30</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">2</td><td align="right">413,811-413,548</td><td align="center">264</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">3</td><td align="right">413,313-413,038</td><td align="center">276</td><td align="center">No</td></tr><tr><td></td><td></td><td></td><td align="center">4</td><td align="right">412,112&#x02013;411,980</td><td align="center">133</td><td align="center">Yes</td></tr><tr><td align="center"><italic>ULBP31</italic></td><td align="center">pseudogene</td><td align="center">-</td><td align="center">3</td><td align="right">423,435-423,164</td><td align="center">272</td><td align="center">Yes</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Repetitive element composition of the minor and major <italic>ULBP </italic>gene clusters</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Repetitive element</td><td align="center">Minor <italic>ULBP </italic>cluster</td><td align="center">Major <italic>ULBP </italic>cluster</td></tr></thead><tbody><tr><td align="left">SINE</td><td align="right">5,681 bp (10.1%)</td><td align="right">37,368 bp (8.8%)</td></tr><tr><td align="left">LINE</td><td align="right">9,973 bp (17.7%)</td><td align="right">69,177 bp (16.3%)</td></tr><tr><td align="left">LTR</td><td align="right">2,406 bp (4.3%)</td><td align="right">18,161 bp (4.3%)</td></tr><tr><td align="left">DNA (including MER1/2)</td><td align="right">2,388 bp (4.2%)</td><td align="right">14,749 bp (3.5%)</td></tr><tr><td align="left">Small RNA</td><td align="right">0 bp (0.0%)</td><td align="right">219 bp (0.1%)</td></tr><tr><td align="left">Satellites</td><td align="right">0 bp (0.0%)</td><td align="right">0 bp (0.0%)</td></tr><tr><td align="left">Simple repeats</td><td align="right">893 bp (1.6%)</td><td align="right">2,446 bp (0.6%)</td></tr><tr><td align="left">Low complexity</td><td align="right">394 bp (0.7%)</td><td align="right">1,614 bp (0.4%)</td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="left">Total repetitive elements</td><td align="right">21,735 bp (38.6%)</td><td align="right">143,734 bp (34.0%)</td></tr></tbody></table><table-wrap-foot><p>Repetitive element statistics were generated only from genomic regions flanked by <italic>ULBP </italic>loci. These include 56,390 bp of the minor cluster and 423,435 bp of the major cluster.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Likelihood ratio tests of &#x003c9; variation and identification of molecular sites under positive selection in ten cattle ULBP proteins</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">-2(M2 vs M1)</td><td align="center">-2(M3 vs M1)</td><td align="center">-2(M8 vs M7)</td><td align="center">Parameter estimates for M8</td><td align="left">Positively selected sites</td></tr></thead><tbody><tr><td align="center">3.2 (P &#x0003c; 0.25)</td><td align="center">10.6 (P &#x0003c; 0.05)</td><td align="center">8.1 (P &#x0003c; 0.025)</td><td align="center">p<sub>1 </sub>= 0.279, p<sub>0 </sub>= 0.721 &#x003c9; = 1.904, &#x003b2; (60.6, 99.0)</td><td align="left"><bold>64</bold>, <bold>68</bold>, 69, 70, 99, <bold>106</bold>, 144, <bold>165</bold>, 178,<bold>190</bold>, <bold>192</bold>, <bold>198</bold>, <bold><italic>206</italic></bold></td></tr></tbody></table><table-wrap-foot><p>Accession numbers associated with the sequences analyzed are listed in the Methods section. M1, M2, M3, M7 and M8 refer to maximum likelihood models of &#x003c9; ratios, and -2(M2 vs M1), -2(M3 vs M1) and -2(M8 vs M7) indicate the negative of two times the log likelihood difference between the selection and neutral models compared. P values for the test statistics are shown in parentheses. For M8, p<sub>1 </sub>is the proportion of positively selected sites, <italic>p</italic><sub>0 </sub>is the proportion of sites not under positive selection, &#x003c9; is the d<sub>N</sub>/d<sub>S </sub>ratio for the selected sites, and &#x003b2;(p, q) describes the beta distribution function. Positively selected ULBP sites are presented according to their numbered positions in the ULBP1 preprotein sequence. Posterior probabilities for positively selected sites are represented in normal text (probability &#x0003e; 0.90), bold text (probability &#x0003e; 0.95), and italicized bold text (probability &#x0003e; 0.99).</p></table-wrap-foot></table-wrap></sec></back></article> 